Join our email list for exclusive offers! OFF! 👏
Sale!

RAD-150 Powder (TLB-150) | 2 Grams

 Selling fast! Get yours today  Same-day shipping available

Original price was: $126.99.Current price is: $114.99.

In stock

Description

Research-Grade SARM Derivative Reference Material

RAD-150 (TLB-150) Powder — 2 Grams

RAD-150, also designated TLB-150 or RAD-140 benzoate, is a synthetic benzoate ester of the non-steroidal selective androgen receptor modulator RAD-140 (testolone). It is catalogued as an androgen receptor modulator for research into esterified SARM analogs. This listing is a research-grade reference compound supplied in powder form for in vitro and laboratory investigation. Identity and purity are third-party verified and documented by a downloadable Certificate of Analysis.

  • 99.8% purity (HPLC)
  • Third-party verified
  • 2,050 mg net
  • Public COA
  • UV-resistant foil pouch
Technical Reference

Specifications & Documentation

Compound
RAD-150 (TLB-150 / RAD-140 benzoate)
IUPAC Name
4-[[(1R,2S)-2-(benzoyloxy)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]propyl]amino]-2-chloro-3-methylbenzonitrile
CAS Number
1208070-53-4
Molecular Formula
C₂₇H₂₀ClN₅O₃
Molar Mass
497.93 g/mol
Compound Class
Esterified SARM derivative · Benzoate ester of RAD-140
Parent Compound
RAD-140 (testolone), CAS 1182367-47-0
WADA Classification
Prohibited — Class S1.2 (Other Anabolic Agents), which covers SARMs
Form
Crystalline powder
Net Quantity
2,050 mg per pouch
Why Verification Matters

Quality & Analytical Transparency

Independent analysis has repeatedly found that materials sold online as SARMs are frequently mislabeled or adulterated. A 2017 JAMA investigation that chemically analyzed products marketed as SARMs found that only a minority accurately matched their labeled contents, and a substantial share contained unapproved or entirely different substances.[4] Third-party testing is the control that distinguishes a documented reference compound from an unverified one.

99.8%HPLC Purity
HPLCPurity Method
MSIdentity Confirmation
GLPTesting Standard
Scientific Background

Research Context

RAD-150 is structurally derived from RAD-140, a non-steroidal SARM developed by Radius Health whose preclinical characterization was published in 2011.[1] RAD-150 adds a benzoate ester at the hydroxyl group of the RAD-140 backbone, a modification of the kind commonly used to alter lipophilicity and metabolic stability. Unlike its parent compound, RAD-150 has essentially no dedicated peer-reviewed literature: its pharmacology, metabolism, and toxicology have not been characterized in published studies, and properties often attributed to it are extrapolated from RAD-140. RAD-140 itself has been associated with liver enzyme elevations in a Phase I trial and with case reports of drug-induced liver injury.[2][3] RAD-150 has never been evaluated in humans.

This material is supplied strictly as a reference compound to support such laboratory investigation. It is not a therapeutic product, dietary supplement, or sports supplement, and no clinical or performance outcomes are claimed or implied for any individual.

Regulatory Status

Compliance & Legal Status

RAD-150 (TLB-150) is an unapproved research compound that has not been approved by the U.S. Food and Drug Administration for human use. It is not a dietary supplement, and marketing it for human ingestion is unlawful. It is supplied exclusively for laboratory research purposes.

FDA StatusNot approved for human use; not a dietary or sports supplement.
WADA StatusProhibited at all times — Class S1.2, Other Anabolic Agents, which covers SARMs.[5]
Intended UseLaboratory / in vitro research reference material only.
Not ForHuman or animal consumption, diagnosis, treatment, or performance use.
Citations

Scientific References

  1. Miller CP, Shomali M, Lyttle CR, et al. Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS Med Chem Lett. 2011;2(2):124–129.
  2. LoRusso P, Hamilton E, Ma C, et al. A first-in-human phase 1 study of a novel selective androgen receptor modulator (SARM), RAD140, in ER+/HER2– metastatic breast cancer. Clin Breast Cancer. 2022;22(1):67–77.
  3. Flores JE, Chitturi S, Walker S. Drug-induced liver injury by selective androgenic receptor modulators. Hepatol Commun. 2020;4(3):450–452.
  4. Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA. 2017;318(20):2004–2010.
  5. World Anti-Doping Agency. The Prohibited List, Section S1.2: Other Anabolic Agents. WADA.org.

Research Disclaimer

For laboratory research use only. This preparation is not approved by the FDA for human use. RAD-150 / TLB-150 is not a dietary or sports supplement and is not intended for human or animal consumption.

All products on this website are intended exclusively for research and development purposes. The statements herein have not been evaluated by the U.S. Food and Drug Administration. Neither the statements nor the products are intended to diagnose, treat, cure, or prevent any disease. Sports Technology Labs are chemical suppliers, not medical practitioners; our expertise is sourcing and quality control.

Additional information

Weight 0.25 oz
Dimensions 3 × 0.3 × 4 in

Related Products